Response to Nivolumab and Ipilimumab in Microsatellite Instability-High (MSI-H) Cervical Carcinoma with Acquired Resistance to Pembrolizumab: A Case Report and Literature Review
Author(s) -
Gahyun Gim,
Yeseul Kim,
Yeonggyeong Park,
Min Jeong Kim,
Myungwoo Nam,
Woojung Yang,
Samantha Duarte,
Chan Mi Jung,
Elena Vagia,
Pedro Viveiros,
Young Kwang Chae
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac095
Subject(s) - nivolumab , medicine , ipilimumab , pembrolizumab , oncology , immunotherapy , microsatellite instability , combination therapy , cancer , allele , biochemistry , chemistry , microsatellite , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom